Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Despite the existence of plentiful evidence on the efficacy of anti-osteoporosis drugs (AOD) to prevent fractures in randomized controlled trials, there is a need for data on their comparative effectiveness and safety in actual practice. We aimed to compare the anti-fracture effectiveness of available AODs based on the observed risk of fracture while on treatment using ‘real world’ data from the UK NHS and Spanish healthcare records.

Original publication




Conference paper



Publication Date